Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
321.00    -4.00 (-1.23%)
Bid:
314.00
Ask:
328.00
Spread: 14.00 (4.459%)
Market Cap: £40.73m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

16 Jul 2014 07:00

RNS Number : 3912M
BrainJuicer Group PLC
16 July 2014
 

 

 

 

 

Press Release 16 July 2014

 

 

BrainJuicer Group PLC

 ("BrainJuicer", the "Company", and the "Group")

 

Pre close trading update

 

BrainJuicer (AIM: BJU), the international online market research agency, today releases the following half-year ("H1") update on trading. The Company will announce its results for the 6 months to 30 June 2014 on 19 September 2014.

 

Overall the Company grew revenue by some 4% over the same period in the previous year (10% in constant currency terms). Sales were marginally down in the UK and US versus strong comparable periods, but increased in all of our other regions. Sales of BrainJuicer's unique "Juicy" products have continued to grow, and represented 81% of our business in H1, compared to 74% in 2013 as a whole.

 

As noted in our AGM Statement in May, we have been expanding some of our client account management teams over recent months as we prepare for future growth. So far, the incremental costs of this have been largely offset by savings achieved elsewhere in the business, and H1 overheads were very similar to those in H1 2013.

 

The fall in the BrainJuicer share price since the AGM meant that the much increased share based payment charge indicated in our AGM statement did not materialise in H1. The charge for H1 2014 will be some £213,000, compared with £96,000 in H1 last year. The charge for the full year will be influenced by the share price during the remainder of the financial year.

 

BrainJuicer's financial position and cash generation remain strong. At the end of June, the Company had a cash balance of £2.5m (December 2013: £6.2m), after having returned £1.9m to shareholders by way of ordinary and special dividends (totaling 15.0p per share) and a further £1.5m by way of share buy-backs and cash settlements of the Group's management equity incentive plan.

 

As ever, revenue visibility is limited as we move into the second half of the year, which is traditionally when the bulk of our profit is generated. Subject to this caveat, the Board considers that the Company is in a position to meet market profit expectations for the full year to December 2014.

 

The Company can be found at www.brainjuicer.com.

 

- Ends -

 

 

 

For further information, please contact:

BrainJuicer Group PLC

John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer www.brainjuicer.com

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVVORSNABAAR
Date   Source Headline
18th Aug 20177:00 amRNSTrading Update
11th Jul 20171:18 pmRNSAnnual Report and Notice of AGM
3rd Jul 20177:59 amRNSTotal Voting Rights
26th Jun 201711:23 amRNSDirector/PDMR Shareholding
16th Jun 20171:33 pmRNSExercise of Options and Director Dealing
15th Jun 20177:00 amRNSDividend Declaration
15th Jun 20177:00 amRNSDirectorate Change
15th Jun 20177:00 amRNSFinancial results to 31 March 2017
11th May 20175:47 pmRNSHolding(s) in Company
19th Apr 20177:00 amRNSTrading Update
3rd Apr 20177:00 amRNSChange of Name
24th Mar 20177:00 amRNSChange of Name
22nd Mar 20174:31 pmRNSGrant of Options
22nd Mar 20173:44 pmRNSResult of General Meeting
1st Mar 20172:02 pmRNSTotal Voting Rights
28th Feb 20172:58 pmRNSDirector/PDMR Shareholding
24th Feb 20177:00 amRNSNotice of GM
10th Feb 20173:46 pmRNSExercise of Options
9th Feb 20177:00 amRNSResults for the 12 months ended 31 December 2016
7th Feb 20177:00 amRNSBoard Appointment
20th Jan 20177:00 amRNSTrading Update
9th Dec 20167:00 amRNSTrading Update
1st Dec 201612:45 pmRNSTotal Voting Rights
1st Nov 20165:34 pmRNSTransaction in Own Shares
1st Nov 20161:35 pmRNSTotal Voting Rights
13th Oct 20165:34 pmRNSTransaction in Own Shares
12th Oct 20161:44 pmRNSTransaction in Own Shares
4th Oct 20167:00 amRNSDirectorPDMR Dealing and Transaction in Own Shares
30th Sep 20165:15 pmRNSTransaction in Own Shares
27th Sep 20164:57 pmRNSExercise of Options, PDMR Shareholding
22nd Sep 20167:00 amRNSExercise of Options and Transaction in Own Shares
22nd Sep 20167:00 amRNSTransaction in Own Shares
20th Sep 20166:23 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSTransaction in Own Shares
16th Sep 20167:00 amRNSInterim Results
16th Sep 20167:00 amRNSDividends and Share Buyback
9th Sep 20164:39 pmRNSHolding(s) in Company
9th Sep 20161:20 pmRNSHolding(s) in Company
26th Aug 201611:42 amRNSHolding(s) in Company
16th Aug 20164:15 pmRNSAdditional Listing
15th Jul 20167:00 amRNSTrading Update
20th Jun 20164:40 pmRNSTransaction in Own Shares
6th Jun 20164:45 pmRNSDirector Dealing
6th Jun 201611:17 amRNSDirector Dealing
3rd Jun 20162:17 pmRNSHolding(s) in Company
2nd Jun 20166:02 pmRNSDirector Dealing and Transaction in Own Shares
18th May 20165:46 pmRNSDirector Dealing and Transaction in Own Shares
6th May 201612:19 pmRNSResult of AGM
4th May 20163:55 pmRNSTransaction in Own Shares
22nd Apr 20163:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.